David B. Page

5.6k citations
60 papers · 3.3k · 2 hit papers · h-index 22

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Colorectal Cancer Treatments and Studies
    • Cancer Cells and Metastasis
  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune cells in cancer

Papers in

    • Cancer Immunotherapy and Biomarkers 42
    • CAR-T cell therapy research 14
    • Cancer Treatment and Pharmacology 6
    • HER2/EGFR in Cancer Research 5
    • Immunotherapy and Immune Responses 23
    • Immune Cell Function and Interaction 7

David B. Page

59 papers receiving 3.2k citations

David B. Page's Hit Papers

Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies 2015 · 1.2k citations
1.2k0+4+8Years since publication2505007501000

Peers

David B. Page
Comparison fields: 5 of 121
  • Oncology 2.4k
  • Immunology 1.3k
  • Pulmonary and Respiratory Medicine 628
  • Cancer Research 283
  • Critical Care and Intensive Care Medicine 90
Replace Hans‐Joachim Stemmler with:
Hans‐Joachim Stemmler Germany
Jacobus Pfisterer Germany
Ingo Schmidt‐Wolf Germany
Julie Vincent France
Ajay V. Maker United States
Yohei Hisada United States
Hubert Zirngibl Germany
Freda Passam Australia
Hiroyasu Yokomise Japan
Mustafa Beneklı Türkiye
David B. Page relative to Hans‐Joachim Stemmler Germany Hans‐Joachim Stemmler's profile →
Citations per field
00.5×3.1×
Hans‐Joachim Stemmler · 1×
Citations per year

Countries citing papers authored by David B. Page

Since Specialization
Citations

This map shows the geographic impact of David B. Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Page more than expected).

Fields of papers citing papers by David B. Page

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David B. Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Page. The network helps show where David B. Page may publish in the future.

Co-authors

The 25 scholars most cited alongside David B. Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David B. Page Line = papers co-authored together David B. Page links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
Hit paper breakdown →
20151186
2
Immune Modulation in Cancer with Antibodies
Hit paper breakdown →
2013403
3 2016215
4 2018209
5 2016162
6 2019140
7 2014108
8 201599
9 201884
10 201171
11 202158
12 201740
13
Correlation of clinical and immunological data in a metastatic melanoma patient with heterogeneous tumor responses to ipilimumab therapy.
201036
14
Immunotherapy for the treatment of breast cancer: checkpoint blockade, cancer vaccines, and future directions in combination immunotherapy.
201634
15 202130
16 201627
17 201626
18 202225
19 201924
20 201622

About David B. Page

David B. Page is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 60 papers that have together received 3.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (42 papers), Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (7 papers), Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (5 papers) and Breast Cancer Treatment Studies (5 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.3k citations), Pulmonary and Respiratory Medicine (628 citations), Cancer Research (283 citations) and Critical Care and Intensive Care Medicine (90 citations). David B. Page has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Jedd D. Wolchok, Jarushka Naidoo, Katja Schindler, Mario E. Lacouture, Michael A. Postow, Bob T. Li, Louise C. Connell, Michael A. Postow, James P. Allison and Margaret K. Callahan. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal for ImmunoTherapy of Cancer, Annals of Oncology and Cancer Immunology Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact